East China Pharmaceuticals (000963.SZ): The application for the market approval of ZORYVE 0.15% cream has been accepted.

Zhixin Finance APP News, Huadong Pharmaceutical (000963.SZ) announced that on November 10, 2025, its wholly-owned subsidiary Hangzhou Zormei Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Zormei Huadong") received the "Acceptance Notice" (Acceptance No.: JXHS2500126) issued by the National Medical Products Administration (NMPA), indicating that the application for marketing approval of Roferon-A Cream (ZORYVE) 0.15% has been accepted.